Evidence map›Paper›PMID 40980325›Full record

ReviewFrontiers in microbiology2025

Research progress on bacterial outer membrane vesicles in antibiotic resistance and clinical anti-infective therapy.

Yukang Lu, Zhenzhen Wen, Xiaoyan Liu, Tingting Zhang, Meijin Liu, Linghan Zhang, Jinyou Qiu, Maoyuan Wang

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. IsGut microbes · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Modulation of macrophage survival duringFrontiers in cellular and infection microbiology · 2026
    Review
  10. Tregs and persistentFrontiers in oral health · 2026
    Article
  11. Article
  12. Evaluating Outer Membrane Vesicle Isolation Techniques forAntibiotics (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yukang LuPeople's Hospital of Ganzhou Economic Development Zone, Ganzhou, China.
Zhenzhen WenPeople's Hospital of Ganzhou Economic Development Zone, Ganzhou, China.
Xiaoyan LiuPeople's Hospital of Ganzhou Economic Development Zone, Ganzhou, China.
Tingting ZhangPeople's Hospital of Ganzhou Economic Development Zone, Ganzhou, China.
Meijin LiuPeople's Hospital of Ganzhou Economic Development Zone, Ganzhou, China.
Linghan ZhangPeople's Hospital of Ganzhou Economic Development Zone, Ganzhou, China.
Jinyou QiuPeople's Hospital of Ganzhou Economic Development Zone, Ganzhou, China.
Maoyuan WangPeople's Hospital of Ganzhou Economic Development Zone, Ganzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, bacterial outer membrane vesicles (OMVs)-nanoscale, bilayered membrane structures secreted by Gram-negative bacteria-have attracted considerable attention for their involvement in antibiotic resistance and potential in clinical anti-infective strategies. OMVs encapsulate diverse biomolecules, including proteins, lipids, toxins, and nucleic acids, thereby serving as critical mediators of communication between bacteria and host cells. They contribute to horizontal gene transfer, signal transduction, and biofilm formation, ultimately enhancing bacterial adaptability and resistance. Clinically, OMVs are regarded as promising therapeutic platforms owing to their excellent biocompatibility and intrinsic immunogenicity, with ongoing investigations exploring their roles in vaccine development, targeted drug delivery, and immune modulation. This review highlights the participation of OMVs in resistance mechanisms across common pathogenic bacteria and discusses their emerging applications in infection control. By elucidating the biogenesis and functional mechanisms of OMVs, novel antibacterial strategies may be developed, offering new avenues to address the escalating global challenge of antibiotic resistance.

Indexed as

antibiotic resistancebacterial outer membrane vesiclesclinical anti-infective therapygram-negativebacteriavaccine development

Identifiers

PMID40980325
PMCPMC12443857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.